Epidemiology and Genetic Diversity of Colistin Nonsusceptible Nosocomial Acinetobacter baumannii Strains from Russia for 2013-2014
Open Access
- 17 October 2017
- journal article
- research article
- Published by Hindawi Limited in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 2017, 1-5
- https://doi.org/10.1155/2017/1839190
Abstract
A high level of resistance to carbapenems in Acinetobacter baumannii strains severely limits therapeutic possibilities. Colistin is the last resort drug against such strains, although the cases of resistance to this drug have become more frequent. This article presents the epidemiological features and genetic diversity of colistin nonsusceptible A. baumannii strains collected as part of a national multicenter epidemiological study of the antibiotic resistance of pathogens of nosocomial infections (MARATHON), which was conducted in 2013-2014 in Russia. A total of 527 A. baumannii isolates were collected, 10 (1.9%) of which were nonsusceptible to colistin. The majority of nonsusceptible A. baumannii isolates to colistin showed resistance to carbapenems and had the genes of the acquired OXA-40-like carbapenemases (). In one case, a combination of OXA-23-like + OXA-40-like () genes was identified. One strain had the multidrug-resistant (MDR) phenotype, 6 isolates had extensively drug-resistant (XDR) phenotype, and 3 isolates had pandrug-resistant (PDR) phenotype. Among the colistin nonsusceptible A. baumannii isolates, 6 individual genotypes were identified, most of which belonged to successful international clones (, ; , ; , ).
Keywords
This publication has 17 references indexed in Scilit:
- Acinetobacter baumannii: evolution of a global pathogenPathogens and Disease, 2014
- Eighteen Years of Experience With Acinetobacter baumannii in a Tertiary Care Hospital*Critical Care Medicine, 2013
- Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78BMC Infectious Diseases, 2013
- Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineagesInternational Journal of Antimicrobial Agents, 2013
- Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumanniiDrug Resistance Updates, 2012
- Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategiesJournal of Antimicrobial Chemotherapy, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology & Infection, 2012
- Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic optionsInternational Journal of Antimicrobial Agents, 2012
- Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Naples, Italy, Shows the Emergence of a Novel Epidemic CloneJournal of Clinical Microbiology, 2010
- An increasing threat in hospitals: multidrug-resistant Acinetobacter baumanniiNature Reviews Microbiology, 2007